BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11911970)

  • 1. Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers.
    Nishihara H; Tanaka S; Tsuda M; Oikawa S; Maeda M; Shimizu M; Shinomiya H; Tanigami A; Sawa H; Nagashima K
    Cancer Lett; 2002 Jun; 180(1):55-61. PubMed ID: 11911970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
    Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
    J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging components of the Crk oncogene product: the first identified adaptor protein.
    Matsuda M; Kurata T
    Cell Signal; 1996 Aug; 8(5):335-40. PubMed ID: 8911681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of NGF induced signal transduction from neurite elongation by expression of a mutant adaptor protein v-Crk in PC12 cells.
    Teng KK; Courtney JC; van Bergen en Henegouwen P; Birge RB; Hempstead BL
    Mol Cell Neurosci; 1996; 8(2-3):157-70. PubMed ID: 8918832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The product of the cellular crk gene consists primarily of SH2 and SH3 regions.
    Reichman CT; Mayer BJ; Keshav S; Hanafusa H
    Cell Growth Differ; 1992 Jul; 3(7):451-60. PubMed ID: 1329926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two species of human CRK cDNA encode proteins with distinct biological activities.
    Matsuda M; Tanaka S; Nagata S; Kojima A; Kurata T; Shibuya M
    Mol Cell Biol; 1992 Aug; 12(8):3482-9. PubMed ID: 1630456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for Ras in v-Crk transformation.
    Greulich H; Hanafusa H
    Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crk at the quarter century mark: perspectives in signaling and cancer.
    Kumar S; Fajardo JE; Birge RB; Sriram G
    J Cell Biochem; 2014 May; 115(5):819-25. PubMed ID: 24356912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Crk oncogene product in physiologic signaling.
    Kiyokawa E; Mochizuki N; Kurata T; Matsuda M
    Crit Rev Oncog; 1997; 8(4):329-42. PubMed ID: 9622053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downstream of Crk adaptor signaling pathway: activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G.
    Tanaka S; Ouchi T; Hanafusa H
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2356-61. PubMed ID: 9122199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor.
    Koval AP; Blakesley VA; Roberts CT; Zick Y; Leroith D
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):923-32. PubMed ID: 9480911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification, up-regulation and over-expression of C3G (CRK SH3 domain-binding guanine nucleotide-releasing factor) in non-small cell lung cancers.
    Hirata T; Nagai H; Koizumi K; Okino K; Harada A; Onda M; Nagahata T; Mikami I; Hirai K; Haraguchi S; Jin E; Kawanami O; Shimizu K; Emi M
    J Hum Genet; 2004; 49(6):290-295. PubMed ID: 15138850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells.
    Tanaka S; Hattori S; Kurata T; Nagashima K; Fukui Y; Nakamura S; Matsuda M
    Mol Cell Biol; 1993 Jul; 13(7):4409-15. PubMed ID: 8321240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.
    Miller CT; Chen G; Gharib TG; Wang H; Thomas DG; Misek DE; Giordano TJ; Yee J; Orringer MB; Hanash SM; Beer DG
    Oncogene; 2003 Sep; 22(39):7950-7. PubMed ID: 12970743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins.
    Matsuda M; Mayer BJ; Fukui Y; Hanafusa H
    Science; 1990 Jun; 248(4962):1537-9. PubMed ID: 1694307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Crk adapter protein is essential for
    Spracklen AJ; Thornton-Kolbe EM; Bonner AN; Florea A; Compton PJ; Fernandez-Gonzalez R; Peifer M
    Mol Biol Cell; 2019 Aug; 30(18):2399-2421. PubMed ID: 31318326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation.
    Akagi T; Shishido T; Murata K; Hanafusa H
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7290-5. PubMed ID: 10852971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptor protein Crk induces Src-dependent activation of p38 MAPK in regulation of synovial sarcoma cell proliferation.
    Watanabe T; Tsuda M; Tanaka S; Ohba Y; Kawaguchi H; Majima T; Sawa H; Minami A
    Mol Cancer Res; 2009 Sep; 7(9):1582-92. PubMed ID: 19737974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Drosophila homologue to vertebrate Crk by interaction with MBC.
    Galletta BJ; Niu XP; Erickson MR; Abmayr SM
    Gene; 1999 Mar; 228(1-2):243-52. PubMed ID: 10072777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.